Annual FCF
-$300.33 M
-$179.45 M-148.45%
December 31, 2023
Summary
- As of February 25, 2025, RXRX annual free cash flow is -$300.33 million, with the most recent change of -$179.45 million (-148.45%) on December 31, 2023.
- During the last 3 years, RXRX annual FCF has fallen by -$248.20 million (-476.08%).
- RXRX annual FCF is now -476.08% below its all-time high of -$52.13 million, reached on December 31, 2020.
Performance
RXRX Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly FCF
-$63.79 M
+$22.61 M+26.17%
September 30, 2024
Summary
- As of February 25, 2025, RXRX quarterly free cash flow is -$63.79 million, with the most recent change of +$22.61 million (+26.17%) on September 30, 2024.
- Over the past year, RXRX quarterly FCF has stayed the same.
- RXRX quarterly FCF is now -187.32% below its all-time high of $73.05 million, reached on March 31, 2022.
Performance
RXRX Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM FCF
-$335.63 M
+$9.96 M+2.88%
September 30, 2024
Summary
- As of February 25, 2025, RXRX TTM free cash flow is -$335.63 million, with the most recent change of +$9.96 million (+2.88%) on September 30, 2024.
- Over the past year, RXRX TTM FCF has stayed the same.
- RXRX TTM FCF is now -1714.15% below its all-time high of -$18.50 million, reached on March 31, 2020.
Performance
RXRX TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Free Cash Flow Formula
FCF = Cash From Operations − CAPEX
RXRX Free Cash Flow Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -148.4% | 0.0% | 0.0% |
| 3 y3 years | -476.1% | -21.0% | -177.7% |
| 5 y5 years | -392.7% | -21.0% | -177.7% |
RXRX Free Cash Flow Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -148.4% | at low | -187.3% | +41.5% | -346.4% | +2.9% |
| 5 y | 5-year | -476.1% | at low | -187.3% | +41.5% | -1714.2% | +2.9% |
| alltime | all time | -476.1% | at low | -187.3% | +41.5% | -1714.2% | +2.9% |
Recursion Pharmaceuticals Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$63.79 M(-26.2%) | -$335.63 M(-2.9%) |
| Jun 2024 | - | -$86.40 M(-20.7%) | -$345.60 M(+4.5%) |
| Mar 2024 | - | -$108.95 M(+42.4%) | -$330.63 M(+10.1%) |
| Dec 2023 | -$300.33 M(+148.4%) | -$76.49 M(+3.7%) | -$300.33 M(+8.6%) |
| Sep 2023 | - | -$73.75 M(+3.2%) | -$276.56 M(+4.0%) |
| Jun 2023 | - | -$71.44 M(-9.2%) | -$265.92 M(-2.4%) |
| Mar 2023 | - | -$78.66 M(+49.2%) | -$272.58 M(+125.5%) |
| Dec 2022 | -$120.88 M | -$52.73 M(-16.4%) | -$120.88 M(-9.6%) |
| Sep 2022 | - | -$63.10 M(-19.2%) | -$133.78 M(+17.9%) |
| Jun 2022 | - | -$78.10 M(-206.9%) | -$113.43 M(+50.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | $73.05 M(-211.3%) | -$75.19 M(-62.1%) |
| Dec 2021 | -$198.41 M(+280.6%) | -$65.62 M(+53.5%) | -$198.41 M(+54.0%) |
| Sep 2021 | - | -$42.75 M(+7.2%) | -$128.81 M(+21.1%) |
| Jun 2021 | - | -$39.87 M(-20.5%) | -$106.34 M(+26.9%) |
| Mar 2021 | - | -$50.17 M(-1359.9%) | -$83.80 M(+60.7%) |
| Dec 2020 | -$52.13 M(-14.5%) | - | - |
| Dec 2020 | - | $3.98 M(-119.6%) | -$52.13 M(-7.1%) |
| Sep 2020 | - | -$20.28 M(+17.0%) | -$56.12 M(+56.6%) |
| Jun 2020 | - | -$17.33 M(-6.3%) | -$35.83 M(+93.7%) |
| Mar 2020 | - | -$18.50 M | -$18.50 M |
| Dec 2019 | -$60.95 M | - | - |
FAQ
- What is Recursion Pharmaceuticals annual free cash flow?
- What is the all time high annual FCF for Recursion Pharmaceuticals?
- What is Recursion Pharmaceuticals annual FCF year-on-year change?
- What is Recursion Pharmaceuticals quarterly free cash flow?
- What is the all time high quarterly FCF for Recursion Pharmaceuticals?
- What is Recursion Pharmaceuticals quarterly FCF year-on-year change?
- What is Recursion Pharmaceuticals TTM free cash flow?
- What is the all time high TTM FCF for Recursion Pharmaceuticals?
- What is Recursion Pharmaceuticals TTM FCF year-on-year change?
What is Recursion Pharmaceuticals annual free cash flow?
The current annual FCF of RXRX is -$300.33 M
What is the all time high annual FCF for Recursion Pharmaceuticals?
Recursion Pharmaceuticals all-time high annual free cash flow is -$52.13 M
What is Recursion Pharmaceuticals annual FCF year-on-year change?
Over the past year, RXRX annual free cash flow has changed by -$179.45 M (-148.45%)
What is Recursion Pharmaceuticals quarterly free cash flow?
The current quarterly FCF of RXRX is -$63.79 M
What is the all time high quarterly FCF for Recursion Pharmaceuticals?
Recursion Pharmaceuticals all-time high quarterly free cash flow is $73.05 M
What is Recursion Pharmaceuticals quarterly FCF year-on-year change?
Over the past year, RXRX quarterly free cash flow has changed by $0.00 (0.00%)
What is Recursion Pharmaceuticals TTM free cash flow?
The current TTM FCF of RXRX is -$335.63 M
What is the all time high TTM FCF for Recursion Pharmaceuticals?
Recursion Pharmaceuticals all-time high TTM free cash flow is -$18.50 M
What is Recursion Pharmaceuticals TTM FCF year-on-year change?
Over the past year, RXRX TTM free cash flow has changed by $0.00 (0.00%)